Estimating the cost savings due to the effect of kremezin in delaying the initiation of dialysis treatments among patients with chronic renal failure

Journal of Preventive Medicine and Public Health

Volumn 39, Issue 2, 2006, Pages 149-158

  Kang, Hye Young ^a   Cho, Woohyun ^b   Lee, Sunmi ^a   Kim, Hyung Jong ^c   Lee, Ho Yong ^b   Woo, Tae Wook ^d  

^a Yonsei University   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c CHA University   (South Korea)

^d CJ Corporation   (South Korea)

Author keywords

Chronic renal failure; Cost; Dialysis; Economic analysis; Kremezin

Indexed keywords

AST 120; CARBON; OXIDE;

ADULT; AGED; ARTICLE; CHRONIC KIDNEY FAILURE; COMPARATIVE STUDY; COST CONTROL; ECONOMICS; FEMALE; HUMAN; KOREA; MALE; MIDDLE AGED; RENAL REPLACEMENT THERAPY;

ADULT; AGED; CARBON; COST CONTROL; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; KOREA; MALE; MIDDLE AGED; OXIDES; RENAL DIALYSIS;

EID: 33646342982     PISSN: 19758375     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Goldman L, Ausiello D. Oi 117. Chronic Renal Failure. In: Cecil Textbook of Medicine. 22nd ed. Madelphia: Saunders; 2004. pp708-716.
2. Kim JC, Jo ST, Yoon JY, Kim GH, Jeon RW, Kim HJ, Chae DW, Noh JW, Son BK, Koo Jr. Depression in chronic hemodialysis patients: risk factors and effects on nutritional parameters. Korean J Intern Med 2002; 62(1): 77-82 (Korean).
3. Min HJ, Ko KS, Kim MS, Moon SS, Park WD, Park CW, Suh SY, Yu BH, Lee YK, Chung TS, Shin YT. The influencing factors of quality of life in hemodialysis patients. Korean J Nephrol 1999; 18(5): 714-732 (Korean).
4. Neto JF, Ferraz MB, Cendoroglo M, Draibe S, Yu L, Sesso R. Quality of life at the initiation of maintenance dialysis treatment: a comparison between the SF-36 and the KDQ question. Qual Life Res 2000; 9:101-107.
5. Sesso R, Rodrigues-Neto JF, Ferraz MB. Impact of socioeconomic status on the quality of life of ESRD patients. Am J Kidney Dis 2003; 41(1): 186-195.
6. Mittal SK, Ahem L, Raster E, Maesaka JK, Fishbane S. Self-assessed quality of life in peritoneal dialysis patients. Am J Nephrol 2001; 21(3): 215-220.
7. Kobayashi N, Maeda A, Horikoshi S, Shirato I, Tomino Y, Ise M. Effects of oral adsorbent AST-120 (Kremezin) on renal function and glomerular injury in early-stage renal failure of subtotal nephrectomized rats. Nephron 2002; 91(3): 480-485..
8. Niwa T, Nomura T, Sugiyama S, MiyazaM T, Tsukushi S, Tsutsui S. The protein metabolite hypothesis, a model for the progression of renal failure: an oral adsorbent lowers indoxylsulfate levels in undialyzed uremic patients. Kidney Int 1997; 62:23-28.
9. Niwa T, Ise M. Indoxyl sulfate, a circulating uremic toxin, stimulate the progression of glomerular sclerosis. J Lab Clin Med 1994; 124(1): 96-104.
10. Yoshida Y, Sakai T, Ise M. Effects of oral adsorbent in the rat model of chronic renal failure. Nephron 1992; 62(3): 305-314.
11. Motojima M, Nishijima F, Ikoma M, Kawamura T, Yoshioka T, Fogo AB, Sakai T, Ichikawa I. Role for "uremic toxin" in the progressive loss of intact nephrons in chronic renalfailure.Kidney Int 1991; 40(3): 461-469.
12. Yoshinobu T, Toshio O, Norihiro S. Effect of Kremezinon diabetic renal failure. J Pract Diabet 2003; 20(6): 721-725 (Japanese).
13. Naoki M, Hidetaka N, Katsutoshi K. Effect of oral adsorbent on diabetic renal failure patients with relation to level of serum bete-2-microglobulin at the time of first prescription of the drug. Kidney Dial 2002; 53(3): 397-402 (Japanese).
14. Chizuru I, Michiko K, Sanae L Estimating the effect of oraladsorbent AST-120 on delay of the initiation of dialysis in patients with chronic renal failure. Prog Med 2000; 20: 2047-2050 (Japanese).
15. Shoze K, Keizo K, Yoshiji Y. The effect of AST-120 on delaying initiation of dialysis therapy in end-stage renal disease. Dialysis 1992; 32(5): 119-130 (Japanese).
16. Mitch WE, Walser M, Buffington GA, Lemann J Jr. A simple method of estimating progression of chronic renal failure. Lancet 1976; 2(7999): 1326-1328.
17. Owada A, Nakao M, Koike J, Ujiie K, Tomita K, Shiigai T. Effect of oral adsorbent AST-120 on the progression of chronic renal failure: A randomized controlled study. Kidney Int 1997; 63: S188-S190.
18. Yorioka N, Ito T, Masaki T, Ogata S, Asakimori Y, Tanji C, Kyuden Y, Komiya Y, Kumagai J, Janjguchi Y, Kohno N. Dose-dependent effect of an oral adsorbent, AST-120, in patients with early chronic renal failure. J Int Med Res 2002; 30:467-475.
19. Yoshinobu E, Toshio O, Norihiro S, Shyuuka U. Effect of Kremezin on diabetic renal failure. JPractDiabet; 20(60): 721-725.
20. Owada a, Shiigai T. Effects of oral adsorbent AST-120 concurrent with a low-protein diet on the progression of chronic renal failure. Am J Nephrol 1996; 16; 124-127.
21. TM) in Acute Coronary Heart Disease: Results of Korea. 2002.
22. Korean Society of Nephrology. http://www.ks-aor.kr/yo/yo2-m-2 htm. October, 2003.
23. Drummond MF, ÓBrien B, Stoddart GL, Torrance GW. Methods for the Economic Evaluation of Health Care Programs. Oxford Medical Publications 2nd Ed; 1997.
24. Korean National Statistical Office. Gender- and Age- Specific Labor Force Participation, 2002.
25. Gutman RA, Stead WW, Robinson RR. Physical activity and employment status of patients on maintenance dialysis. N Engl J Med 1981; 304(6): 309-313